MedTrace Logo

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers

NCT02873117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5154

Last updated 2018-02-26

No results posted yet for this study

Summary

This is a multicenter, cohort study based on medico-administrative data from pathology laboratory registries and drug reimbursement files (CNAM-TS).

Conditions

  • Benign Prostate Hyperplasia

Interventions

OTHER

Prostate biopsy, prostatectomy or prostate resection

Collection of prostate examination

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873117 on ClinicalTrials.gov